RNA-dependent RNA polymerase — Drug Target

All drugs that target RNA-dependent RNA polymerase — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Nucleoside analog

Marketed (1)

• Current Regimen · University of Chicago · Nucleoside analog · Infectious Diseases
  Repurposed to treat COVID-19 by inhibiting viral replication.

Phase 3 pipeline (1)

• Remdesivir-HU · University of Pecs · Nucleoside analog · Infectious Diseases
  Remdesivir-HU is an antiviral medication that works by inhibiting viral RNA-dependent RNA polymerase.